Written By: Pharmacally Medical News Desk Novo Nordisk presented new phase 3 data on cagrilintide, a once-weekly amylin analogue, at the European Association for the Study of Diabetes (EASD) congress which is happening in Vienna, Austria from 15 to 19 September 2025
Use a large gauge needle to draw out all solution
MyPeptidesLab Under construction We're putting the finishing touches on the new site
Instead of shaking the vial, swirl it slowly until the powder is completely dissolved, as shaking can damage the delicate peptide structures
A rich blue glass bottle that provides enhanced protection from light exposure, making it an excellent choice for customers who prefer additional shielding for a peptide-based formula
The calculator lets you test different reconstitution volumes before committing, giving you full control of your setup